Skip to main content
. 2014 Feb 27;22(6):586–595. doi: 10.1007/s12282-014-0524-4

Table 5.

First site of recurrence in terms of pCR and subtype

Category First site of recurrence (%) p value
Soft tissue Bone Viscera Brain
QpCR
 pCR 3 (50.0) 0 3 (50.0) 0 0.26
 Non-pCR 17 (27.9) 9 (14.8) 27 (44.2) 8 (13.1)
CpCR
 pCR 3 (50.0) 0 3 (50.0) 0 0.26
 Non-pCR 17 (27.9) 9 (14.8) 27 (44.2) 8 (13.1)
CpCRbn
 pCR 2 (40.0) 0 3 (60.0) 0 0.38
 Non-pCR 18 (29.0) 9 (14.5) 27 (43.6) 8 (12.9)
SpCR
 pCR 2 (50.0) 0 2 (50.0) 0 0.46
 Non-pCR 18 (28.6) 9 (14.3) 28 (44.4) 8 (12.7)
SpCRbn
 pCR 1 (33.3) 0 2 (66.7) 0 0.60
 Non-pCR 19 (29.7) 9 (14.0) 28 (43.8) 8 (12.5)
JBCS
 Grade 3 3 (50.0) 0 3 (50.0) 0 0.26
 Grade 2b 0 0 0 0
 Grade 0–2a 17 (27.9) 9 (14.8) 27 (44.2) 8 (13.1)
Subtype
 Luminal 10 (27.8) 7 (19.4) 17 (47.2) 2 (5.6) 0.13
 Luminal/Her2-positive 0 0 5 (83.3) 1 (16.7)
 Her2-positive 2 (40.0) 0 2 (40.0) 1 (20.0)
 Triple negative 8 (40.0) 2 (10.0) 6 (30.0) 4 (20.0)

JBCS Japanese Breast Cancer Society